Navigation Links
ClearWay Minnesota(SM) Funded Study Helps Loved Ones Quit Smoking
Date:9/13/2013

MINNEAPOLIS, Sept. 13, 2013 /PRNewswire/ -- A statewide study is testing a novel idea – teaching non-smokers new ways to approach and support a friend or family member about their smoking. The study is funded by ClearWay Minnesota, an independent nonprofit organization dedicated to reducing the harm of tobacco in Minnesota.

"Friends and family really want to help their smoker quit smoking," said Raymond Boyle, ClearWay Minnesota Director of Research. "Nonsmokers have tried nagging their smokers, or hiding their cigarettes. This is trying a new way, a new approach. Friends and family learn strategies to become support persons for the smoker in their life."

Non-smokers participation is conveniently done by mail and telephone. The project goal is to encourage smokers to get help to quit smoking. In addition, participants receive a gift for taking part in the study. Interested participants have until September 30, 2013 to enroll in the study.

In a previous study, researchers found support persons were learning about nicotine addiction and new ways to have a conversation about quitting smoking with the smoker in their life. In this current study, non-smokers in Minnesota will learn how to motivate their smoker and learn ways to help them quit. The smoker can receive free QUITPLAN Helpline services, which include coaching over the phone, personalized program to help them quit and free nicotine replacement therapy in the form of patches, lozenges or gum.

"We want smokers to feel motivated by the support around them, and this will encourage them to keep trying to quit smoking," Boyle said. "Family and friends can start the support and the helpline can continue that support."

This study is open until September 30, 2013 to all non-smoking Minnesota residents, ages 18 and older.  For more information on the study and how to help a smoker quit, visit www.supportasmoker.com, or call the study information and registration line at 1-800-957-2950.

About ClearWay MinnesotaSM
ClearWay Minnesota is an independent, nonprofit organization that improves the health of Minnesotans by reducing the harm caused by tobacco. ClearWay Minnesota serves Minnesota through its grant-making program, QUITPLAN® stop-smoking services and statewide outreach activities. It is funded with 3 percent of the state's 1998 tobacco settlement. For more information on ClearWay Minnesota or QUITPLAN Services, call 952-767-1400 or visit www.clearwaymn.org.


'/>"/>
SOURCE ClearWay Minnesota
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Domains $760 million co-investment partnership with Rusnano bears fruit with fifth transaction funded
2. Researchers Funded By The Pancreatic Cancer Action Network Leverage $9.15 Million Investment By The Organization Into $91 Million In Subsequent Pancreatic Cancer Research Funding
3. RxAlly And Shenandoah University Partner On Grant-Funded Pharmacy Initiative To Increase Pneumonia Immunization Rates
4. Dyadic Netherlands To Develop Enzymes For EU-Funded Research Consortium
5. Michael J. Fox Foundation-Funded Study Identifies Best Dyskinesia Clinical Rating Scale
6. ViiV Healthcare Presents Positive Data from Phase IIIb/IV Study of Dolutegravir vs Darunavir in Treatment-Naive Adults with HIV-1
7. Bullet Bio Provides Update On Recent Financing And Results From Proof-Of-Concept Study For Lead Product Candidate
8. Mint Medical Education & Accelarad team up to deliver a Vascular Ultrasound Case Study Review System
9. Newly-Published Study Concludes Stretta May Be More Desirable GERD Treatment than Chronic PPI Use or Anti-Reflux Surgery in Some Patients
10. Adynxx Completes Patient Enrollment in Phase 2 Clinical Study of Lead Therapeutic for Prevention of Pain, AYX1
11. Elcelyx Therapeutics NewMet for Type 2 Diabetes Meets Primary Endpoint in Phase 2b Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... BOSTON , March 27, 2017 /PRNewswire/ ... company and Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a ... of innovative therapies based upon tetracycline chemistry, announced ... for the treatment of moderate to severe acne ... is a once-daily, oral, narrow spectrum tetracycline-derived antibiotic ...
(Date:3/27/2017)... -- Impax Laboratories, Inc. (NASDAQ: IPXL)today announced that its Board ... as Impax,s President and Chief Executive Officer and a ... Mr. Bisaro will succeed J. Kevin Buchi , ... Officer since December of 2016. With ... Bisaro, 56, is an accomplished global business leader who ...
(Date:3/27/2017)... , March 27, 2017  PhaseRx, Inc. ... for life-threatening inherited liver diseases in children, today ... full year ended December 31, 2016 and provided ... "PhaseRx continued to make progress during the ... positive results from our non-human primate safety study, and ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... March 27, 2017 , ... ... CE Certificate of Conformity for the Smart System® 20/20. CE Certification builds upon ... industry standards and specifications such as ANSI, ISO and proven test methods used ...
(Date:3/27/2017)... ... March 27, 2017 , ... Osteitis pubis ... type of groin injury, it occurs when the muscles around the pelvis become ... and around the lower torso, as well as accompanying tenderness and weakness. Without ...
(Date:3/27/2017)... ... 2017 , ... EpiGentek , a Farmingdale, NY-based biotech ... methylation “gold rush” with their established portfolio of optimized assay kits that measure ... m6A , RNA methylation has received a new burst in interest as ...
(Date:3/27/2017)... ... , ... Janet Schloz is still in shock after receiving a $2,500 Academic Award from ... time,” she said. , She thinks the coming week is going to be a very ... have to help my students.” , The award will allow the 4th grade teacher at ...
(Date:3/27/2017)... ... March 27, 2017 , ... Sodium determination is consistently ... and require expert user knowledge. In a live webinar on April 11th and ... yet highly accurate, determination of sodium. , It has long been known that ...
Breaking Medicine News(10 mins):